| (I object to you calling revenue meaningless when you brought up country population.) World medicine spending[0]: $1.2 trillion US prescription drug spending[1][2]: $348 billion (29% of world spending) US drug advertising[3]: $30 billion (1% of US drug spending) Health insurance net earnings[4]: $23 billion (0.8% of US drug spending) [0] https://www.statista.com/statistics/280572/medicine-spending... [1] Median estimate from https://www.healthaffairs.org/do/10.1377/hblog20180726.67059... [2] Another source puts the US proportion of pharmaceutical revenue at 33%: https://www.statista.com/statistics/784420/share-of-worldwid... [3] https://www.seattletimes.com/business/us-medical-marketing-r... [4] https://naic.org/documents/topic_insurance_industry_snapshot... |
Population creates limits for the amount of useful medication that can be provided, inefficiency is practically unbound. It’s not that on it’s own say Heath insurance overhead and profit is that expensive it’s simply yet another implementation detail unrelated to actually providing heathcare.